The integration of the Internet of things cloud platform can help enterprises' IT infrastructure monitor, analyze and control major network connections.Platforms such as device management and connection management have high global recognition in the IT industry.Radiotherapy quality assurance phantomsis an embodiment of cancer treatment with radiation. It is widely used in cancer treatment through clinical linear accelerator, cobalt 60, low dose and high dose radiotherapy units, among which radiotherapy quality assurance phantomsis used in quality assurance program.
This report contains market size and forecasts of Radiation Therapy Quality Assurance Phantoms in global, including the following market information:
Global Radiation Therapy Quality Assurance Phantoms Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Radiation Therapy Quality Assurance Phantoms Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Radiation Therapy Quality Assurance Phantoms companies in 2021 (%)
The global Radiation Therapy Quality Assurance Phantoms market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Cubic Phantom Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Radiation Therapy Quality Assurance Phantoms include Computerized Imaging Reference Systems (CIRS), Fluke Biomedical, IBA, Modus Medical Devices, PTW Freiburg, Standard Imaging, Sun Nuclear Corporation and The Phantom Laboratory, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Radiation Therapy Quality Assurance Phantoms manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Radiation Therapy Quality Assurance Phantoms Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Radiation Therapy Quality Assurance Phantoms Market Segment Percentages, by Type, 2021 (%)
Cubic Phantom
Disk Phantom
Cylindrical Phantom
Global Radiation Therapy Quality Assurance Phantoms Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Radiation Therapy Quality Assurance Phantoms Market Segment Percentages, by Application, 2021 (%)
Prostate Cancer
Breast Cancer
Lung Cancer
Colorectal Cancer
Head and Neck Cancers
Skin Cancer
Other
Global Radiation Therapy Quality Assurance Phantoms Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Radiation Therapy Quality Assurance Phantoms Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Radiation Therapy Quality Assurance Phantoms revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Radiation Therapy Quality Assurance Phantoms revenues share in global market, 2021 (%)
Key companies Radiation Therapy Quality Assurance Phantoms sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Radiation Therapy Quality Assurance Phantoms sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Computerized Imaging Reference Systems (CIRS)
Fluke Biomedical
IBA
Modus Medical Devices
PTW Freiburg
Standard Imaging
Sun Nuclear Corporation
The Phantom Laboratory